Verzenio is used to treat advanced hormone-related breast cancer. This drug is used only if the tumor tests negative for a protein called human epidermal growth factor receptor 2 (HER2). HER2 can speed up the growth of cancer cells. To buy Verzenio 150 mg or to know its price contact 3S Corporation.
Manufacturer : Eli Lilly and Company
Strengths available : 150mg
Form : Tablets
Dosage : Usual Adult Dose for Breast Cancer – -In combination with fulvestrant or an aromatase inhibitor: 150 mg orally twice a day. As Monotherapy: 200 mg orally twice a day. Duration of Therapy: Until disease progression or unacceptable toxicity.
Storage : Store at 20°C to 25°C
Is the medicine FDA approved : Yes
Date of Approval : September 28, 2017
Common side effects are back, tarry stools, bleeding gums, bloating or swelling of the face, arms, hands, lower legs, or feet, blood in the urine or stools, chest pain, chills, confusion, cough, decreased urination, diarrhea, difficulty breathing, dizziness, dry mouth, fainting, fever, hoarseness, increased heart rate, irregular heartbeat, light headedness, lower back or side pain, pain in the chest, groin, or legs, especially the calves, painful or difficult urination, pale skin, pinpoint red spots on the skin, rapid breathing, rapid weight gain, severe, sudden headache, slurred speech, sore throat, sores, ulcers, or white spots on the lips or in the mouth, stomach pain, sudden loss of coordination, sudden, severe weakness or numbness in the arm or leg, sunken eyes, swollen glands, thirst, tingling of the hands or feet, troubled breathing with exertion, unusual bleeding or bruising, unusual tiredness or weakness, unusual weight gain or loss, vision changes, wrinkled skin.
Rare side effects are blurred vision, clay-colored stools, dark urine, decreased appetite, fast heartbeat, general feeling of discomfort or illness, itching, loss of appetite, nausea, numbness or tingling in the face, arms, or legs, rapid, shallow breathing, severe headache, skin rash, stomach pain or tenderness, swelling of the feet or lower legs, thickening of bronchial secretions, trouble speaking or walking, vomiting, yellow eyes or skin.